Definitive Contract HHSN266200400071C
Award Date 9/30/04
Potential Completion Date 2/6/15
Potential Value $75M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Not listed
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of goods, to provide research and development facilities. The contract, valued at $8,045,553.00, is a definitive contract without a set-aside designation, with an ultimate completion date of December 30, 2009. The funding agency is the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. In addition to this contract, Sanofi...
- This is a cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, with a ceiling value of $86,670,401.90, is for biomedical (advanced) products and services. The prime contractor is Janssen Vaccines & Prevention B.V., a foreign-owned for-profit organization. The contract does not have a set-aside designation and has an ultimate completion date...
- This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The purpose of the contract is to provide medical countermeasures, such as vaccines and adjuvants, for pandemic preparedness and response, as well as to provide storage and stability of materials for the Department of Health and Human Services (HHS). The contract is a delivery order...
- This federal contract award is for the provision of VACCINES to a U.S. government agency. The prime contractor is Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods and medical supplies. The contract has a total ceiling value of $582,081.35 and was awarded on a firm fixed price basis without any set-aside designation. The award is associated with a larger Indefinite Delivery Vehicle (IDV) potentially valued at $5.87 billion that Sanofi Pasteur holds with the...
- This is a firm fixed price delivery order awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to Sanofi Pasteur Inc. to provide vaccines for stock. The contract has a ceiling value of $120,272.19 and a performance period ending on May 23, 2015. As the prime contractor, Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of goods that has received numerous awards from government agencies, including the Department of Veterans Affairs,...
- This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Sanofi Pasteur Inc. The contract is for the maintenance of a raw material supply chain of embryonated hen eggs to support the production of pandemic influenza vaccines. The contract has a ceiling value of $49,895,006.34 and is a cost-plus-fixed-fee arrangement with an ultimate completion date of January 31, 2025. The contract is not set aside for any special...
- This is a firm fixed price delivery order awarded by the Office of the Assistant Secretary for Administration, a civilian agency, to Sanofi Pasteur Inc. for the provision of vaccines. The contract has a ceiling value of $98,094.20 and an ultimate completion date of January 12, 2019. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of goods that holds several indefinite delivery vehicles (IDVs) with federal agencies, including a 5-year, $5.87 billion IDIQ with the HHS Office of the...
- This $1,673,472.00 firm fixed price delivery order was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Sanofi Pasteur Inc., a foreign-owned for-profit vaccine manufacturer, on September 30, 2016. The order is part of a larger 5-year Indefinite Delivery Vehicle (IDV) contract potentially valued at $5.87 billion to supply medical countermeasures for emerging health threats. The work will be performed at Sanofi Pasteur's...
- This contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The purpose of the requirement is to provide medical countermeasures, such as vaccines and adjuvants, for pandemic preparedness and response or as required by the Department of Health and Human Services (HHS). The contract includes services for storage and stability of vaccine bulk lots...
- This is a firm fixed price delivery order issued by the Office of the Assistant Secretary for Administration, a civilian agency, to Sanofi Pasteur Inc. for the provision of SANOFI VACCINES FOR STOCK. The contract has a ceiling value of $89,151.87 and was awarded on April 14, 2015 with a completion date of April 23, 2015. This award is not associated with a set-aside designation. Sanofi Pasteur Inc. is a foreign-owned, for-profit organization that manufactures vaccines, pharmaceuticals, and...
This is a Cost Plus Fixed Fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Sanofi Pasteur Biologics, LLC for the production and testing of a Modified Vaccinia Ankara (MVA) vaccine. The contract award has a ceiling value of $74,940,566.62 and an ultimate completion date of February 6, 2015. The contract is not designated as a set-aside. As a child company of the Sanofi group, Sanofi Pasteur Biologics, LLC is a foreign-owned, for-profit organization. This contract award is part of NIAID's broader efforts to develop and evaluate medical countermeasures against infectious diseases.
Generated 11/24/24, 9:42 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 12 | Funding Only Action | $1.6m | 12/23/14 | |
| 11 | Funding Only Action | $945.8k | 7/8/14 | |
| 10 | Funding Only Action | $5.1m | 2/7/14 | |
| 9 | Other Administrative Action | $0 | 12/13/13 | |
| 8 | Funding Only Action | $243.6k | 6/10/11 |